Adiponectin secreted by tubular renal cells during LPS exposure worsens the cellular inflammatory damage

Journal of Nephrology

Volumn 29, Issue 2, 2016, Pages 185-194

  Perri, Anna ^a   Vizza, Donatella ^a   Lupinacci, Simona ^a   Toteda, Giuseppina ^a   De Amicis, Francesca ^b   Leone, Francesca ^a   Gigliotti, Paolo ^a   Lofaro, Danilo ^a   La Russa, Antonella ^a   Bonofiglio, Renzo ^a  

^a Annunziata Hospital   (Italy)

^b UNIVERSITY OF CALABRIA   (Italy)

Author keywords

Adiponectin; AP 1 transcription factor; Kidney; NFkB transcription factor; Tumor necrosis factor

Indexed keywords

ADIPONECTIN; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INTERLEUKIN 6; LIPOPOLYSACCHARIDE; MESSENGER RNA; MONOCYTE CHEMOTACTIC PROTEIN 1; TUMOR NECROSIS FACTOR ALPHA; ADIPONECTIN RECEPTOR; ADIPOQ PROTEIN, HUMAN; ADIPOR1 PROTEIN, HUMAN; AUTACOID; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE KINASE; MITOGEN ACTIVATED PROTEIN KINASE; STRESS ACTIVATED PROTEIN KINASE; TRANSCRIPTION FACTOR;

ARTICLE; CELL DAMAGE; CONTROLLED STUDY; ENZYME LINKED IMMUNOSORBENT ASSAY; HUMAN; HUMAN CELL; IMMUNOPRECIPITATION; INFLAMMATION; KIDNEY CELL; PROTEIN EXPRESSION; REAL TIME POLYMERASE CHAIN REACTION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; RNA INTERFERENCE; SIGNAL TRANSDUCTION; TRANSIENT TRANSFECTION; UPREGULATION; WESTERN BLOTTING; ACTIVE TRANSPORT; AUTOCRINE EFFECT; BINDING SITE; CELL LINE; CHEMICALLY INDUCED; DRUG EFFECTS; GENETIC TRANSFECTION; GENETICS; KIDNEY PROXIMAL TUBULE; METABOLISM; NEPHRITIS; PATHOLOGY; PHOSPHORYLATION; PROMOTER REGION; SECRETION (PROCESS); TIME FACTOR;

ACTIVE TRANSPORT, CELL NUCLEUS; ADIPONECTIN; AMP-ACTIVATED PROTEIN KINASES; AUTOCRINE COMMUNICATION; BINDING SITES; CELL LINE; EXTRACELLULAR SIGNAL-REGULATED MAP KINASES; HUMANS; INFLAMMATION MEDIATORS; JNK MITOGEN-ACTIVATED PROTEIN KINASES; KIDNEY TUBULES, PROXIMAL; LIPOPOLYSACCHARIDES; NEPHRITIS; PHOSPHORYLATION; PROMOTER REGIONS, GENETIC; RECEPTORS, ADIPONECTIN; RNA INTERFERENCE; SIGNAL TRANSDUCTION; TIME FACTORS; TRANSCRIPTION FACTORS; TRANSFECTION; UP-REGULATION;

EID: 84961257106     PISSN: 11218428     EISSN: 17246059     Source Type: Journal    
DOI: 10.1007/s40620-015-0220-2     Document Type: Article

References (27)

1. Tilg H, Moschen AR (2006) Adipocytokines: mediators linking adipose tissue, inflammation and immunity. Nat Rev Immunol 6(10):772–783. doi:10.1038/nri1937
2. Waki H, Yamauchi T, Kamon J, Ito Y, Uchida S, Kita S, Hara K, Hada Y, Vasseur F, Froguel P, Kimura S, Nagai R, Kadowaki T (2003) Impaired multimerization of human adiponectin mutants associated with diabetes. Molecular structure and multimer formation of adiponectin. J Biol Chem 278(41):40352–40363. doi:10.1074/jbc.M300365200
3. Thundyil J, Pavlovski D, Sobey CG, Arumugam TV (2012) Adiponectin receptor signalling in the brain. Br J Pharmacol 165(2):313–327. doi:10.1111/j.1476-5381.2011.01560.x
4. Dadson K, Liu Y, Sweeney G (2011) Adiponectin action: a combination of endocrine and autocrine/paracrine effects. Front Endocrinol 2:62. doi:10.3389/fendo.2011.00062
5. Kishida K, Funahashi T, Shimomura I (2012) Molecular mechanisms of diabetes and atherosclerosis: role of adiponectin. Endocr Metab Immune Disord Drug Targets 12(2):118–131
6. Fantuzzi G (2008) Adiponectin and inflammation: consensus and controversy. J Allergy Clin Immunol 121(2):326–330. doi:10.1016/j.jaci.2007.10.018
7. Jia T, Carrero JJ, Lindholm B, Stenvinkel P (2012) The complex role of adiponectin in chronic kidney disease. Biochimie 94(10):2150–2156. doi:10.1016/j.biochi.2012.02.024
8. Toussirot E, Binda D, Gueugnon C, Dumoulin G (2012) Adiponectin in autoimmune diseases. Curr Med Chem 19(32):5474–5480
9. Addabbo F, Nacci C, De Benedictis L, Leo V, Tarquinio M, Quon MJ, Montagnani M (2011) Globular adiponectin counteracts VCAM-1-mediated monocyte adhesion via AdipoR1/NF-kappaB/COX-2 signaling in human aortic endothelial cells. Am J Physiol Endocrinol Metabol 301(6):E1143–E1154. doi:10.1152/ajpendo.00208.2011
10. Ajuwon KM, Spurlock ME (2005) Adiponectin inhibits LPS-induced NF-kappaB activation and IL-6 production and increases PPARgamma2 expression in adipocytes. Am J Physiol Regul Integr Comp Physiol 288(5):R1220–R1225. doi:10.1152/ajpregu.00397.2004
11. Haugen F, Drevon CA (2007) Activation of nuclear factor-kappaB by high molecular weight and globular adiponectin. Endocrinology 148(11):5478–5486. doi:10.1210/en.2007-0370
12. Park PH, McMullen MR, Huang H, Thakur V, Nagy LE (2007) Short-term treatment of RAW264.7 macrophages with adiponectin increases tumor necrosis factor-alpha (TNF-alpha) expression via ERK1/2 activation and Egr-1 expression: role of TNF-alpha in adiponectin-stimulated interleukin-10 production. J Biol Chem 282(30):21695–21703. doi:10.1074/jbc.M701419200
13. Tang CH, Chiu YC, Tan TW, Yang RS, Fu WM (2007) Adiponectin enhances IL-6 production in human synovial fibroblast via an AdipoR1 receptor, AMPK, p38, and NF-kappa B pathway. J Immunol (Baltimore, Md: 1950) 179(8):5483–5492
14. Tsao TS, Murrey HE, Hug C, Lee DH, Lodish HF (2002) Oligomerization state-dependent activation of NF-kappa B signaling pathway by adipocyte complement-related protein of 30 kDa (Acrp30). J Biol Chem 277(33):29359–29362. doi:10.1074/jbc.C200312200
15. Zoico E, Garbin U, Olioso D, Mazzali G, Fratta Pasini AM, Di Francesco V, Sepe A, Cominacini L, Zamboni M (2009) The effects of adiponectin on interleukin-6 and MCP-1 secretion in lipopolysaccharide-treated 3T3-L1 adipocytes: role of the NF-kappaB pathway. Int J Mol Med 24(6):847–851
16. Fantuzzi G (2013) Adiponectin in inflammatory and immune-mediated diseases. Cytokine 64(1):1–10. doi:10.1016/j.cyto.2013.06.317
17. Cheng CF, Lian WS, Chen SH, Lai PF, Li HF, Lan YF, Cheng WT, Lin H (2012) Protective effects of adiponectin against renal ischemia-reperfusion injury via prostacyclin-PPARalpha-heme oxygenase-1 signaling pathway. J Cell Physiol 227(1):239–249. doi:10.1002/jcp.22726
18. Jin X, Chen J, Hu Z, Chan L, Wang Y (2013) Genetic deficiency of adiponectin protects against acute kidney injury. Kidney Int 83(4):604–614. doi:10.1038/ki.2012.408
19. Rutkowski JM, Wang ZV, Park AS, Zhang J, Zhang D, Hu MC, Moe OW, Susztak K, Scherer PE (2013) Adiponectin promotes functional recovery after podocyte ablation. J Am Soc Nephrol JASN 24(2):268–282. doi:10.1681/asn.2012040414
20. Perri A, Vizza D, Lofaro D, Gigliotti P, Leone F, Brunelli E, Malivindi R, De Amicis F, Romeo F, De Stefano R, Papalia T, Bonofiglio R (2013) Adiponectin is expressed and secreted by renal tubular epithelial cells. J Nephrol 26(6):1049–1054. doi:10.5301/jn.5000269
21. Vizza D, Perri A, Lofaro D, Toteda G, Lupinacci S, Leone F, Gigliotti P, Papalia T, Bonofiglio R (2013) Exposure to nerve growth factor worsens nephrotoxic effect induced by Cyclosporine A in HK-2 cells. PLoS One 8(11):e80113. doi:10.1371/journal.pone.0080113
22. Yao J, Mackman N, Edgington TS, Fan ST (1997) Lipopolysaccharide induction of the tumor necrosis factor-alpha promoter in human monocytic cells. Regulation by Egr-1, c-Jun, and NF-kappaB transcription factors. J Biol Chem 272(28):17795–17801
23. Bancroft CC, Chen Z, Yeh J, Sunwoo JB, Yeh NT, Jackson S, Jackson C, Van Waes C (2002) Effects of pharmacologic antagonists of epidermal growth factor receptor, PI3 K and MEK signal kinases on NF-kappaB and AP-1 activation and IL-8 and VEGF expression in human head and neck squamous cell carcinoma lines. Int J Cancer J Int du Cancer 99(4):538–548. doi:10.1002/ijc.10398
24. Favata MF, Horiuchi KY, Manos EJ, Daulerio AJ, Stradley DA, Feeser WS, Van Dyk DE, Pitts WJ, Earl RA, Hobbs F, Copeland RA, Magolda RL, Scherle PA, Trzaskos JM (1998) Identification of a novel inhibitor of mitogen-activated protein kinase kinase. J Biol Chem 273(29):18623–18632
25. Saadane A, Masters S, DiDonato J, Li J, Berger M (2007) Parthenolide inhibits IkappaB kinase, NF-kappaB activation, and inflammatory response in cystic fibrosis cells and mice. Am J Respir Cell Mol Biol 36(6):728–736. doi:10.1165/rcmb.2006-0323OC
26. Song H, Chan J, Rovin BH (2009) Induction of chemokine expression by adiponectin in vitro is isoform dependent. Trans Res J Lab Clin Med 154(1):18–26. doi:10.1016/j.trsl.2009.04.003
27. Guma M, Firestein GS (2012) c-Jun N-Terminal Kinase in Inflammation and Rheumatic Diseases. Open Rheumatol J 6:220–231. doi:10.2174/1874312901206010220